Financial considerations in expanded access policy for gene therapies: A tough nut to crack?

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

Access to Document

@article{497e2a669e474aad8dbd6bb8db4e6e8c,

title = "Financial considerations in expanded access policy for gene therapies: A tough nut to crack?",

author = "Polak, {Tobias B.} and Bunnik, {Eline M.}",

year = "2021",

month = may,

day = "7",

doi = "10.1016/j.ymthe.2021.04.030",

language = "English",

volume = "29",

pages = "1936",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - Financial considerations in expanded access policy for gene therapies

T2 - A tough nut to crack?

AU - Polak, Tobias B.

AU - Bunnik, Eline M.

PY - 2021/5/7

Y1 - 2021/5/7

UR - http://www.scopus.com/inward/record.url?scp=85106901674&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2021.04.030

DO - 10.1016/j.ymthe.2021.04.030

M3 - Comment/Letter to the editor

C2 - 33964226

AN - SCOPUS:85106901674

VL - 29

SP - 1936

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 6

ER -